Alumis Inc.
closed
ALMS
Capital Structure & Economics
Trust SizeN/A
Unit Price$17.00
Warrant Coverage-
Sponsor Promote20%
Implied Equity Architecture
| Public Trust Allocation | N/A |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $17.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedJun 7, 2024
SearchingTarget Pending
Maturation Wall
Jul 1, 2024
Announced Target / M&A
- Target CompanyACELYRIN, Inc.
- Sectorbiopharmaceutical
Board & Officers
- CEO
- Director
- Alan B. Colowick, M.D., M.P.H.Director
- Patrick Machado, J.D.Director
- Sapna Srivastava, Ph.D.Director
- Director
- Zhengbin Yao, Ph.D.Director
- Director
- Jörn Drappa, M.D., Ph.D.Director
- David M. Goldstein, Ph.D.Director
- Roy HardimanDirector
- John SchroerDirector
- Sara KleinDirector
- Derrick RichardsonDirector
Advanced Structuring Terms
| Target Sectors | biopharmaceutical |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.